Biologics Discovery and Development

All-in-one biointelligence
ecosystem

Exponential power to transform drug discovery

Our biointelligence ecosystem integrates AI, deep data, and advanced lab research to make complex biology computable and actionable for discovery and development across therapeutic and anti-drug antibodies, diagnostics, vaccines, and peptide therapeutics. Because no two programs are the same, the platform is designed to adapt to your specific targets, modalities, and program priorities.

News
Tech
Blog
Lab
Case Studies
New Brand
News

Dengue vaccine  

A highly conserved epitope across all four dengue virus serotypes uncovered with LensAI opens new directions in vaccine design, showing how pattern detection and scale are expanding what’s discoverable. Explore the full story.

Tech

Bio-Native LensAI

Intelligence built from biology, not just trained on it. LensAI links sequence, structure, function and literature to reveal deeper biological meaning—see how contextual intelligence is reshaping molecular discovery.

Blog

Epitope Mapping

Molecular precision aligned with x-ray crystallography. A recent LensAI case study shows computational insights reaching crystallographic-level accuracy for epitope mapping, highlighting how predictive context strengthens experimental confidence.

Lab

Advanced Lab Research

Where experimentation meets computation. Advanced lab research and integrated data insights are designed to deliver stronger starts, deeper biological context, and greater confidence in the clinic.

Case Study Collection

CaseXCase

A series dedicated to LensAI in action. Each example applies explainable intelligence across discovery workflows—explore how contextual analysis turns insight into measurable impact.

New Brand

Darwin Inspired 

Our brand is shaped by the principles of Darwin’s daily walk of observation. MindWalk unites science and technology—a shared path shaped by curiosity and connection.

Customizable ecosystem

An integrated platform built to decipher biological complexities

We’re at an inflection point in biologic discovery—driven by the integration of AI, data, and advanced lab research within a customizable ecosystem that accelerates precision, context, and speed.

Working together, AI Data Lab, interlocking circles

Bio-Native AI

Drive discovery. Built to interpret biology from the start, LensAI™ connects molecular, structural, and functional data to create clarity across complex biology.

Deep Data Integration

Provide context. HYFTs® link over 25 billion biological relationships within LensAI, transforming siloed data into organized, discovery-ready insight.

Advanced Lab Research

Advance results. With 15+ molecules in the clinic, our lab works closely with partners to generate diverse, high-value leads supported by LensAI analysis.

Research highlights & innovation news

Argenx read the article Genmab read news Janssen Pharma read the news NIH read the news Novo Nordisk read the article Onco Response read the news MJ Fox Foundation see filing

What people are saying:

The MindWalk Rapid Prime immunization method and their downstream antibody discovery technology proved pivotal to Acumen's success, enabling timely identification of our human immunotherapeutic, sabirnetug, currently in Phase 2 clinical trials.”

Co-Founder and Chief Scientific Advisor, Acumen Pharmaceuticals

We partnered with MindWalk to generate specific binders against targets in autoimmunity and inflammation. Their proven expertise and customized discovery approach stood out immediately, and results from both their laboratory and LensAI platform exceeded expectations.”

Vice President Discovery, GentiBio

The B cell Select platform was central in developing our lead immunoinhibitory receptor drug candidates, which are now in phase I/II clinical trials. MindWalk's strategic approach, deep experience and technical know-how were essential to our discovery efforts.”

CSO, OncoResponse

MindWalk’s LensAI platform, powered by HYFT technology, was central to optimizing our Pan-Amyloid Immunotherapy candidates for neurodegenerative disease. Their in silico screening, developability analysis, and protein engineering accelerated our discovery process and strengthened candidate performance.”

CEO, Amyl Therapeutics

Powered by experts

We are technologists and scientists working side-by-side. With deep experience in both, we deliver integrated solutions aimed at reshaping the future of discovery.

Case Studies

See validated insights that redefine workflows and optimize discovery success.

Scientific Posters

Discover how MindWalk powers smarter, faster paths from concept to clinic.

Blogs

Explore latest ideas reshaping the future of discovery.

Ready to MindWalk?

Upcoming Events

Join us at an upcoming event.

hubXchange Ab Tx
Munich, Germany
Dec 1, 2025
 

AET San Diego
San Diego USA
Dec 14-17, 2025
 

PMWC 2026
Silicon Valley USA
Mar 4-6, 2026
 

PEGS Boston
Boston USA
May 11-15, 2026